Corticosteroids in COVID-19 ARDS
Hallie C. Prescott, Todd W. Rice
Abstract
Pierre-François Dequin, MD, PhD; Nicholas Heming, MD, PhD; Ferhat Meziani, MD, PhD; Gaëtan Plantefève, MD; Guillaume Voiriot, MD, PhD; Julio Badié, MD; Bruno François, MD; Cécile Aubron, MD, PhD; Jean-Damien Ricard, MD, PhD; Stephan Ehrmann, MD, PhD; Youenn Jouan, MD, PhD; Antoine Guillon, MD, PhD; Marie Leclerc, MSc; Carine Coffre, MSc; Hélène Bourgoin, PharmD; Céline Lengellé, PharmD; Caroline Caille-Fénérol, MSc; Elsa Tavernier, PhD; Sarah Zohar, PhD; Bruno Giraudeau, PhD; Djillali Annane, MD, PhD; Amélie Le Gouge, MSc; CAPE COVID Trial Group and the CRICS-TriGGERSep Network
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakHumanitiesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ArtVirologyPathologyOutbreakDiseaseInfectious disease (medical specialty)Respiratory Support and MechanismsLong-Term Effects of COVID-19Intensive Care Unit Cognitive Disorders